Page 30 - Sciences Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Open Offer to Qualifying Shareholders to raise up to a further £1.0m Cenkos Securities plc appointed joint broker RUA Life Sciences plc (AIM: RUA or the "Company" or the "Group"), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer, is pleased to announce it has conditionally raised approximately £6.0 million by way of a Placing and Subscription to new and existing investors. Furthermore, to provide Shareholders with the opportunity to also subscribe for new Ordinary Shares, the Compan...

Toward the end of trading Friday, the Dow traded up 0.08% to 30,023.53 while the NASDAQ fell 0.52% to 12,341.36. The S&P also fell, dropping 0.30% to 3,657.04.

TMCnet News SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast [December 11, 2020] SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast – Immune Stimulation Augmented by +1,300% at 6-months Post-NPS Treatment – – Statistically Significant Difference of Duration of Immune Response of NPS vs. Control: p=0.000094 -    – Data to be Presented Today at the San Anton...

60 Stocks Moving In Thursday's Mid-Day Session Benzinga 12/10/2020 Gainers Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its Chinese partner, EOC Pharma will commence a new Phase 2 clinical trial of Immutep's eftilagimod alpha in up to 152 metastatic breast cancer patients in China. Immutep said the study follows encouraging data reported by it in its APIAC Phase 2b study announced at the end of March and presented at the SABCS. Greenwich LifeSciences, Inc. (NASDAQ: GLSI) shares surged 67.4% to $95.60. Greenwich LifeSciences shares jumped 998% on Wedn...